£89.91

It has never been this cheap. We have no record of a lower price.

£90 today · cheaper than every other day in the last 3 months

Humana Molecular Mechanisms of Dementia (Contemporary Neuroscience)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£95.18 £89.38 £90.65 £91.91 £93.18 £94.44 £95.71 11 August 2026 20 August 2026 29 August 2026 07 September 2026 17 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 2 price levels

Days at Price
Current Price
3 days · current 35 days 0 9 18 26 35 £90 £95 Days at Price

Price Analysis

Most common price: £95 (35 days, 92.1%)

Price range: £90 - £95

Price levels: 2 different prices over 38 days

Description
The past decade has witnessed a revolution in the attempts of scientists to under stand the molecular basis of dementia. Although dementia, as defined by global cogni tive decline involving gradual loss of memory, reasoning, judgment, and orientation, presents most commonly in the form of Alzheimer's disease (AD), an assortment of other less common disorders, such as prion and Pick's disease, can also lead to symp toms that are similar to those observed in patients with AD. The primary goal of Molecular Mechanisms of Dementia is to address the various mechanisms and multi faceted approaches currently being employed to more clearly delineate the etiological and pathogenic events responsible for the onset of dementia. Perhaps the greatest boon to obtaining a clearer understanding of the causes of AD has come from genetic and molecular biological studies carried out over the past decade. At the genetic level, it has become increasingly clear that AD is a heteroge neous disorder that can be broadly classified into two categories. "Late onset" (>60 yr) cases, which account for the vast majority of AD, genetically involve "susceptibility" genes representing risk factors for the disease (e. g. , inheritance of the 84 allele of the Apolipoprotein E gene). In many cases, the susceptibility gene can act as a "modifier" that modulates the pathogenic cascade occurring subsequent to a separate etiological event "initiating" or "causing" the disorder.

Product Specifications
Brand
Humana
Format
paperback
ASIN
1475758898
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain
Amazon UK
Publication Date
21 March 2013
Listed Since
20 September 2013

Barcode

No barcode data available

Similar Products You Might Like

Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology
86% match

Alzheimer's Disease: Advances in Genetics, Molecular and Cellular Biology

Springer

£110.08 23 Oct 2026
Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)
84% match

Alzheimer's Disease: Methods and Protocols: 32 (Methods in Molecular Medicine, 32)

Humana

£113.94 22 Oct 2026
Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)
82% match

Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)

Humana

£74.21 23 Oct 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
82% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 22 Oct 2026
Genetic Variants in Alzheimer's Disease
82% match

Genetic Variants in Alzheimer's Disease

Springer

£107.27 29 Aug 2026
Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)
81% match

Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)

Humana

£52.60 15 Sep 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
81% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.42 21 Oct 2026
Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3
81% match

Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3

£112.13 24 Oct 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
81% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£58.50 22 Oct 2026
Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics: 2-volume set
80% match

Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics: 2-volume set

£274.84 04 Nov 2026
Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2
80% match

Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2

£58.23 01 Oct 2026
Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)
80% match

Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)

Humana

£80.65 22 Oct 2026
Animal Models of Dementia: 48 (Neuromethods, 48)
80% match

Animal Models of Dementia: 48 (Neuromethods, 48)

Humana

£104.34 15 Sep 2026
Early Diagnosis of Alzheimer’s Disease (Current Clinical Neurology)
80% match

Early Diagnosis of Alzheimer’s Disease (Current Clinical Neurology)

Humana

£80.67 16 Oct 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
79% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Alzheimer's Disease Research Trends
79% match

Alzheimer's Disease Research Trends

£122.98 31 Aug 2026
Alzheimer Disease: Neuropsychology and Pharmacology
79% match

Alzheimer Disease: Neuropsychology and Pharmacology

Birkhauser

£85.41 03 Nov 2026
Movement Disorders in Dementias
79% match

Movement Disorders in Dementias

Springer

£102.53 22 Oct 2026
Movement Disorders in Dementias
79% match

Movement Disorders in Dementias

Springer

£80.67 21 Oct 2026
Vascular Disease: Molecular Biology and Gene Transfer Protocols: 30 (Methods in Molecular Medicine, 30)
79% match

Vascular Disease: Molecular Biology and Gene Transfer Protocols: 30 (Methods in Molecular Medicine, 30)

Humana

£113.76 23 Oct 2026
78% match

Neurobiology of Alzheimer's Disease (Molecular and Cellular Neurobiology Series)

Oxford University Press

£105.00 31 Aug 2026
Studies on Alzheimer's Disease (Oxidative Stress in Applied Basic Research and Clinical Practice)
78% match

Studies on Alzheimer's Disease (Oxidative Stress in Applied Basic Research and Clinical Practice)

Humana

£113.76 26 Oct 2026
Neuroscience in Medicine
78% match

Neuroscience in Medicine

Humana

£148.21 14 Sep 2026
Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
78% match

Presenilins and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£76.42 24 Oct 2026